Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kreuter (Heidelberg, Germany), F. Bonella (Essen, Germany), N. Blank (Heidelberg , Germany), E. Siegert (Berlin, Germany), J. Henes (Tuebingen, Germany), M. Worm (Berlin , Germany), C. Sunderkoetter (Muenster, Germany), M. Schmalzing (Wuerzburg, Germany), A. Kreuter (Oberhausen , Germany), C. Guenther (Bochum , Germany), L. Susok (Bochum , Germany), G. Zeidler (Treuenbrietzen, Germany), I. Koetter (Hamburg, Germany), U. Mueller-Ladner (Bad Nauheim, Germany), T. Krieg (Cologne, Germany), A. Juche (Berlin, Germany), T. Schmeiser (Wuppertal, Germany), G. Riemekasten (Luebeck , Germany), E. Aberer (Graz, Austria), N. Gaebelein-Wissing (Wuppertal, Germany), J. Distler (Erlangen, Germany), M. Sardy (Munich, Germany), C. Pfeiffer (Ulm, Germany), K. Kuhr (Cologne, Germany), H. Lorenz (Heidelberg , Germany), P. Moinzadeh (Cologne, Germany), N. Hunzelmann (Cologne, Germany). Significance of pulmonary involvement in systemic sclerosis (SSc)– data from the German SSc-network. 3657

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary involvement in systemic sclerosis Source: Eur Respir Monogr 2019; 86: 90-105 Year: 2019 Clinical and laboratory features of systemic sclerosis with pulmonary involvement Source: Eur Respir J 2001; 18: Suppl. 33, 512s Year: 2001 Pulmonary functions in systemic sclerosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Clinical feature of systemic sclerosis associated with pulmonary hypertension: results of one center study Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Pulmonary hypertension in systemic sclerosis: different phenotypes Source: Eur Respir Rev, 26 (145) 170056; 10.1183/16000617.0056-2017 Year: 2017 Pulmonary involvement and exercise limitation in patients with systemic sclerosis Source: Eur Respir J 2004; 24: Suppl. 48, 53s Year: 2004 Pulmonary function in progressive systemic sclerosis Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002 Lung function and pulmonary hypertension in systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease Source: Eur Respir Rev, 27 (148) 170102; 10.1183/16000617.0102-2017 Year: 2018 Minimal skin involvement in systemic sclerosis does not preclude pulmonary involvement – an analysis of the German Network for Systemic Sclerosis (DNSS) Registry Source: Eur Respir J 2007; 30: Suppl. 51, 66s Year: 2007 Experimental modeling of lung involvement due to systemic sclerosis. Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020 Longitudinal functional evaluation of interstitial lung disease in systemic sclerosis Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Evaluation of the functional parameters in scleroderma cases with pulmonary involvement Source: Annual Congress 2009 - Respiratory physiology Year: 2009 Response to PAH specific therapy in systemic sclerosis patients with extensive parenchymal changes and pulmonary hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Screening for pulmonary arterial hypertension in systemic sclerosis Source: Eur Respir Rev 2009; 18: 162-169 Year: 2009 Metabolic profiling of pulmonary vascular phenotypes in systemic sclerosis Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Stress-Doppler-Echocardiography for early detection of systemic sclerosis associated pulmonary arterial hypertension Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 Fluid challenge test and pulmonary haemodynamics in patients with systemic sclerosis Source: International Congress 2017 – PAH and CTEPH Year: 2017 The natural course of systemic sclerosis patients with interstitial lung involvement Source: Eur Respir J 2005; 26: Suppl. 49, 336s Year: 2005 Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening Source: Eur Respir Rev 2011; 20: 270-276 Year: 2011